Chih-Wei Chen is an accomplished scientist with extensive experience in advanced therapies and downstream process development. Currently serving as an Advisor at Eli Lilly and Company since September 2023, Chen previously held the position of Senior Scientist at Genezen from December 2022 to September 2023. Prior to industry roles, Chen completed a Doctor's Degree in Cell/Cellular and Molecular Biology at the University of Illinois Chicago, where involvement as a PhD Candidate spanned from August 2015 to December 2022. Academic achievements also include a Master of Science in Biology from Auburn University, awarded in May 2015 with a perfect GPA of 4.0. Aspiring to lead a research team, Chen's desired career path encompasses research and development in biotechnology and pharmaceutical sectors, with a particular focus on upstream and downstream processing and data analysis.
This person is not in the org chart
This person is not in any teams
This person is not in any offices